Skip to main content
Caplight Logo









Intract Pharma

Intract Pharma

Private
LondonHealthcare & Life Scienceshttps://www.intractpharma.com/

Last Round

Corporate Funding

Sep 16, 2024

Total Funding Raised

$3.87M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Intract Pharma is a biotechnology company that develops and licenses oral drug delivery technologies to replace injectable medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

oral drug deliveryoral biologicsdrug delivery platformlarge molecule deliveryoral formulationbiologic pillscolon-targeted deliveryoral monoclonal antibodiesoral mAbsGI drug deliverytechnology licensingoral peptidesinflammatory bowel diseaseIBD treatmentin-vitro GI models

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Intract Pharma Comparables

Compare Intract Pharma with similar companies based on industry and business-model similarity.

Intract Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Panarum Corp
86%
Bhami's Research Laboratory Private Limited
83%
Plantibodies
82%

Intract Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingSep 16, 2024
GrantMay 28, 2024
Corporate FundingMay 26, 2020
GrantNov 9, 2018
SeedJan 11, 2016

Key People

Founding team and executive leadership

Vipul Yadav

Chief Executive Officer

Executive Team

Intract Pharma Investors

Notable investors and investment history

Intract Pharma investors
InvestorRounds
Eurostars SME programmeGrant
Innovate UKGrant
UCL BusinessSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 116% MoM.

  • Apr 18, 2026

    Monthly visitors increased 305% MoM, reaching 4.7K.

Intract Pharma Filings

Explore SEC and related filing metadata, where available.

Intract Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Intract Pharma's valuation, stock price, and market status.

Is Intract Pharma a public or private company?

Intract Pharma is a private company.

What is the current stock price of Intract Pharma?

Intract Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is Intract Pharma worth (valuation)?

Valuation information for Intract Pharma is not publicly available.

Can I buy Intract Pharma stock?

Intract Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Intract Pharma's last funding round?

Intract Pharma's most recent funding round was Corporate Funding on September 16, 2024.

Who are the main investors in Intract Pharma?

Key investors in Intract Pharma include Eurostars SME programme, Innovate UK, UCL Business.

Will Intract Pharma IPO soon?

No public IPO plans have been announced for Intract Pharma.

How can I track Intract Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Intract Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range9
Year Founded2015
Last FundingSep 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?